Skip to content

Clinical trials

Completed Phase 4 Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 4 Status: Completed Clear all

136 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20023
20036
20041
20059
20066
20077
20089
20095
20105
20118
20126
20139
20145
20155
20169
20174
20186
20195
20206
20216
20225
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed136

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ottawa Hospital Research Institute11
Novartis Pharmaceuticals8
Hoffmann-La Roche7
AstraZeneca6
Institut Claudius Regaud4
Novartis4
Nanjing Medical University3
Pfizer3
Spanish Breast Cancer Research Group3
Beni-Suef University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms136
Neoplasm Metastasis8
Postoperative Pain8
Neoplasms7
Prostatic Neoplasms6
Ovarian Neoplasms5
Osteoporosis4
Pain4
Bone Diseases, Metabolic3
Seroma3

Trials

Showing 1 to 25 of 136. Each trial links to its page on Pharma Observatory.

36 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.